KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: 5

E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells

Esra AYDEMİR COBAN
Didem TECİMEL
Ezgi KASİKCİ
Omer Faruk BAYRAK
Fikrettin SAHİN
Sayfa
230–237
Yayın Tarihi
2020-10-13
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our study suggests that E-cadherin may play differential roles in determining the metastatic characteristics of primary and metastatic pancreatic cancer cells.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pancreatic ductal adenocarcinoma (PDAC) pathology is known for its uncontrollable progress due to highly invasive characteristics and refractory behavior against existing chemotherapies.
📊
Temel Bulgular & Veri:The aberrant expression of CDH1 (expresses the protein E-cadherin) is associated with increased overall survival in various cancers, however, E-cadherin expression in PDAC progression has remained elusive.
💡
Sonuç & Katkı:Our study suggests that E-cadherin may play differential roles in determining the metastatic characteristics of primary and metastatic pancreatic cancer cells.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Panc-1 · AsPC1 · E-cadherin

Abstract

Pancreatic ductal adenocarcinoma (PDAC) pathology is known for its uncontrollable progress due to highly invasive characteristics and refractory behavior against existing chemotherapies. The aberrant expression of CDH1 (expresses the protein E-cadherin) is associated with increased overall survival in various cancers, however, E-cadherin expression in PDAC progression has remained elusive. We investigated the impact of exogenously elevated E-cadherin levels on the tumorigenicity of transduced low grade and metastatic PDAC cell lines, Panc-1 and AsPC-1, respectively. Constitutive expression of E-cadherin promoted a more hybrid E/M state in AsPC-1 cells, while it was associated with the acquisition of a more epithelial-like state in Panc1 cells. Our study suggests that E-cadherin may play differential roles in determining the metastatic characteristics of primary and metastatic pancreatic cancer cells.

🔖

Bu Makaleye Atıf Yap

COBAN, E. A., TECİMEL, D., KASİKCİ, E., BAYRAK, O. F., SAHİN, F. (2020). E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells. Turkish Journal of Biology, Cilt: 44 - Sayı: 5, 230–237. https://ajindex.com/articles/197908

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. Aparicio LA, 2012, CANCER METAST REV, V31, P375, DOI 10.1007/s10555-012-9348-x Bhagwandin VJ, 2009, BBA-MOL BASIS DIS, V1792, P248, DOI 10.1016/j.bbadis.2009.02.007 Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179 CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24 De Santis G, 2009,
  2. ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470 Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200 Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915 Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155 Kroger C, 2019, P NATL ACAD SCI USA, V116, P11553, DOI 10.1073/pnas.1907473116 Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30 Moletta L, 2019,
  3. CANCERS, V11, DOI 10.3390/cancers11070991 Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347 Petrova YI, 2016, MOL BIOL CELL, V27, P3233, DOI 10.1091/mbc.E16-01-0058 Pires BRB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169622 Quinn SN, 2017, MOL CARCINOGEN, V56, P1344, DOI 10.1002/mc.22598 Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143 Rosivatz E, 2004, INT J CANCER, V111, P711, DOI 10.1002/ijc.20317 Smigiel JM, 2018,
  4. CANCERS, V10, DOI 10.3390/cancers10010014 Song YZ, 2019, MOL THER-ONCOLYTICS, V14, P130, DOI 10.1016/j.omto.2019.04.005 Swayden M, 2018,
  5. HELIYON, V4, DOI 10.1016/j.heliyon.2018.e01055 Weidenfeld K, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00381 Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686 Yan YM, 2016, CANCER RES, V76, P2419, DOI 10.1158/0008-5472.CAN-15-1691 Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021 Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7 Zhang Y, 2018, FRONT MED-PRC, V12, P361, DOI 10.1007/s11684-018-0656-6 Zhu ZL, 2018, CELL PHYSIOL BIOCHEM, V46, P238, DOI 10.1159/000488426